Pouvons-nous vraiment traiter le cancer de la prostate avec des virus?

*This webinar is presented in French*

Presenter :
Dr. Jean-Simon Diallo
Date : Le mardi soir 11 avril

Thèmes abordés :

Nous discuterons du développement du cancer de la prostate et du développement de traitements innovateurs utilisant des virus dit "oncolytiques" pour le traitement de ce type de cancer. 

Dr. Jean-Simon Diallo :

Dr. Jean-Simon Diallo est un Scientifique à l'Institute de Recherche de l'Hôpital d'Ottawa et Professeur Associé au département de Biochimie, Microbiologie et Immunologie dans la Faculté de Médecine de l'Université d'Ottawa. Il a complété ses études doctorales à l'Université de Montréal étudiant le Cancer de la Prostate et son post-doctorat à l'Université d'Ottawa. Il travail depuis sur les thérapies combinées comprenant des virus oncolytiques pour le traitement du Cancer.

Expert AngleAbout Expert Angle

Expert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.


Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.

Click here for news archive